Ariceum Therapeutics
Ariceum Therapeutics is a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. The name Ariceum is an anagram of ‘Marie Curie’ whose discovery of radium and polonium have been huge contributions to finding treatments for cancer. Ariceum’s lead targeted systemic radiopharmaceutical candidate, SSO110 (“satoreotide”) labelled with Lutetium-177 (177Lu) and Actinium-255 (255Ac) is an antagonist of the somatostatin type 2 (SSTR2) receptor which is overexpressed in aggressive neuroendocrine tumours (NETs) such as small cell lung cancer (SCLC) or Merkel Cell Carcinoma (MCC), all of which have limited treatment options and poor prognosis. Satoreotide is being developed as a ‘theranostic pair’ for the combined diagnosis and targeted radionuclide treatment of these tumours. Ariceum is also developing a radiolabelled PARP-inhibitor (ATT001), currently in Phase 1 clinical development under the trial name CITADEL-123. ATT001 was part of the acquisition of Theragnostics Ltd which was closed in June 2023. Ariceum Therapeutics, launched in 2021, acquired all rights to satoreotide from Ipsen, which has remained a shareholder of the Company. Ariceum is headquartered in Berlin, with operations in Germany, Switzerland, Australia, the United Kingdom, and the United States. Ariceum is led by a highly experienced management team and supported by specialist investors including EQT Life Sciences (formerly LSP), HealthCap, Pureos Bioventures, Andera Partners, and Earlybird Venture Capital.
7-day free trial · no credit card
Verified contacts
28
available on Kipplo
LinkedIn employees
34
11 to 50 range
Open roles
—
no listings
Distinct roles
19
indexed titles
Tech stack
0
tools in use
Monthly traffic
15
organic / mo
Sign up free to see all 28 verified contacts at Ariceum Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
28 contacts with verified email or phone · masked until revealed.
- AB
Aaron Block
Senior Director Business Development · Other
EmailPhone - AJ
Ana Japaridze
Human Resources Manager · Human Resources
EmailPhone - RG
Raghuvir Gaonkar
Cmc Development Manager · Other
EmailPhone - LR
Liam Rayman
Bta · Research & Development
EmailPhone - PD
Prachi Desai
Scientist · Science
EmailPhone - AP
Anamaria Pop
,, · Other
EmailPhone - CA
Carol Andrea Pregonero Gamez
Project Manager · Other
EmailPhone - CO
Charles Oleforo
, - · Other
EmailPhone - DM
Dennis Mewis
- - - · Other
EmailPhone
Showing 9 of 28 verified contacts
Top roles at Ariceum Therapeutics
19 distinct titles indexed · top 10 shown.
- 2human resources manager
- 2scientist
- 1, -
- 1,,
- 1- - -
- 1bta
- 1chief operating officer
- 1cmc development manager
- 1consultant, acting as head of procurement & supply chain
- 1directeur assurance qualité et gestion qualité
- +9more titles
Sign up to unlock all 28 contacts at Ariceum Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 28 verified contacts at Ariceum Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.